Background Patients with advanced heart failure have bioenergetic abnormalities of skeletal muscle metabolism during exercise. Using 31P magnetic resonance spectroscopy, we sought to determine whether skeletal metabolic responses to exercise are normalized by orthotopic cardiac transplantation.
Background Patients with advanced heart failure have bioenergetic abnormalities of skeletal muscle metabolism during exercise. Using 31P magnetic resonance spectroscopy, we sought to determine whether skeletal metabolic responses to exercise are normalized by orthotopic cardiac transplantation.
Methods and Results Four groups were studied: healthy normal volunteers (n=9), subjects awaiting heart transplantation (n=10), subjects <6 months (mean, 4 months) after transplant (n=9), and subjects >6 months (mean, 15 months) after transplant (n=8). None of the posttransplant patients had biopsy evidence of rejection at the time of study. There were no significant differences in age, preoperative functional class, or symptom duration among the three patient groups. Metabolic responses were monitored in the dominant arm during incremental weight pull exercise and 10 minutes of recovery by 31p magnetic resonance spectroscopy, with measurement of pH and the phosphocreatine (PCr)/(PCr+inor-ganic phosphate [P] ) ratio, an index of PCr concentration. In addition, based on recovery data, the rate of PCr resynthesis was calculated as a measure of oxidative metabolism that is independent of work level, recruitment, or muscle mass, and the effective maximal rate of mitochondrial ATP synthesis (Vma,,) was determined. Analysis was by ANOVA. There were no differences between groups in pH or PCr/(PCr+Pi) at rest.
Compared with the normal control group, the pretransplant group had a decreased exercise duration (11.3±2.5 versus S keletal muscle metabolic responses to exercise are abnormal in patients with congestive heart failure.' By magnetic resonance spectroscopy, patients with congestive heart failure have abnormally rapid depletion of phosphocreatine (PCr) and greater intracellular acidosis during exercise of arm or leg skeletal muscles.2-8 Patients in more advanced heart failure have more deranged skeletal muscle metabolism,59 suggesting that the changes in peripheral muscle may be important determinants of exercise performance in heart failure. This contrasts with the findings from hemodynamic studies, in which there has been a notable dissociation between ejection fraction and other hemodynamic measurements and exercise tolerance.9 '10 The abnormal skeletal muscle metabolism during exercise in patients with congestive heart failure is not due solely to a limitation in blood flow56"1 or differences in muscle bulk or the degree of atrophy.56"12 Based on biopsies of resting muscle, several histological and biochemical changes have been described, including fiber atrophy, a decrease in the percentage of type I fibers, an increase in the percentage of type lIb fibers, a decrease in the oxidative enzymes succinate dehydrogenase and citrate synthetase, and a decrease in the enzyme 8-hydroxyacyl coenzyme A dehydrogenase, which mediates 3-oxidation of fatty acids.3'14 However, these histological and biochemical changes measured at rest did not correlate with 31p metabolic responses measured during exercise. 13 The underlying cause of the abnormal skeletal muscle metabolism is uncertain,' and the extent to which the changes are reversible is largely unknown. However, we and others have recently documented that exercise training protocols, which have minimal effects on cardiac function, can at least in part reverse the skeletal muscle metabolic abnormalities.15-17 Whether heart transplantation reverses the skeletal muscle abnormalities has not been determined. Exercise capacity, although improved after heart transplantation, does not totally normalize. '8-21 In one study, maximal oxygen uptake was only 60% of predicted normal in patients studied a mean of 14 months after transplantation. 21 The cause of reduced exercise capacity after heart transplantation is unclear, but continued skeletal muscle abnormalities might contribute.
The purpose of this study was to determine whether the improvement in central hemodynamics caused by successful heart transplantation is associated with improvements in skeletal muscle metabolic responses to exercise in patients with congestive heart failure. Metabolic responses to exercise were assessed during progressive exercise by 31P magnetic resonance spectroscopy in normal control subjects, in patients with heart failure on the waiting list for transplantation, and in patients early (<6 months) or later (>6 months) after successful orthotopic heart transplantation.
Methods Subjects
Four groups of subjects were studied. Ten subjects with chronic congestive heart failure who were on the heart transplant waiting list were studied. Nine subjects who were early ('6 months) after orthotopic heart transplantation and eight subjects who were late (>6 months) after orthotopic heart transplantation were studied. For comparison, nine agematched normal control subjects (50±4 years old, eight men and one woman) were also studied. All subjects gave informed consent according to a protocol approved by the local ethics committee.
Exercise Testing Protocols for Magnetic Resonance Spectroscopy Studies
The muscle of the dominant arm was studied. Before testing, the body of the flexor digitorum superficialis was identified and a 2-cm-diameter circular area marked with a pen. Incremental exercise was done with the patient supine with the arm extended into the magnet and consisted of pulling a lever connected by a pulley to a bucket at a rate of 40 Examples of resting and stage 5 exercise spectra from a normal subject (top panels) and a subject 3.5 months after heart transplantation (bottom panels). At rest, posttransplant subjects were not different from healthy control subjects. During exercise, however, posttransplant subjects had a lower pH and a lower PCr/(PCr+Pi). Upper left, the three peaks of ATP and the inorganic phosphate (Pi) and phosphocreatine (PCr) peaks are notated. The pH is calculated on the basis of the chemical shift between PCr and Pi. four spectra, then 1.25 minutes for the next four spectra, and 2.5 minutes for the final two spectra.
Quantitative analysis of the time-averaged spectra was performed by previously described methods. 
Results

Patient Characteristics
Patient characteristics are summarized in Table 1 . Coronary artery disease was the underlying cause of heart failure in the majority of patients. All posttransplantation patients were receiving cyclosporine. The mean dose was 390+120 mg/d in the early group and 360±160 mg/d in the late group. Azathioprine was used in eight of the early-posttransplant group (mean dose, 95±38 mg/d) and in seven of the late-posttransplant group (mean dose, 73±46 mg/d). In the early-posttransplant group, five subjects received prednisone (mean dose, 21±20 mg/d), and in the late group, three received prednisone (mean dose, 10± 25 mg/d).
All posttransplant patients had a myocardial biopsy on the day before testing, and none had evidence of rejection. None of the patients had a prior history of severe rejection, and only one subject, in the earlyposttransplant group, had a prior history of a single episode of histologically graded moderate rejection.
The mean New York Heart Association functional class at the time of study was 2.7±1.3 in the pretransplant group and 1.2±0.4 in the early-and 1.1±0.7 in the late-posttransplant groups. The mean ejection fraction in the two groups studied after transplantation was normal. Thus, the posttransplantation patients had successful transplantation as judged by a lack of significant rejection, a good functional class, and normal resting left ventricular systolic function. Rest, Submaximal Exercise, and End-Exercise pH and PCr/(PCr+Pi) At rest, there were no differences between groups in pH or PCr/(PCr+P1) ( Table 2, Fig 1) .
During submaximal exercise, defined as stage 5, pH was significantly different between groups (P<.05) ( Figs  1 and 2) , with all three patient groups having lower values than normal control subjects. Submaximal exercise PCr/(PCr+Pi) was also different between groups (P<.0001), with all three patient groups having lower values than normal control subjects (Fig 3) . PCr indicates phosphocreatine; Pi, inorganic phosphate.
Exercise duration was significantly shorter in all three patient groups compared with normal control subjects (P<.001). At the end of exercise, the PCr/(PCr+Pi) ratio was not different between groups, whereas the pH was higher in the three patient groups compared with normal subjects (P<.O1).
The PCr resynthesis rate varied significantly between groups (P<.001) ( Table 3) , being lowest in the pretransplant and early-posttransplant groups, and highest in the late-posttransplant group (Fig 4) . End-exercise
[ADP] varied significantly between groups (P<.01), being highest in the late-posttransplant group. Vm. also differed between groups (P=.03), with the pretransplant and early-posttransplant groups having the most abnormal values (Fig 5) .
Comparison of Early-and Late-Posttransplant Groups
Compared with the early-posttransplant group, the late group showed trends toward improvements in submaximal values of pH and PCr/(PCr+Pi) and in Vm.X, which were not statistically significant. The PCr resynthesis rate was significantly higher in the late-posttransplant group compared with the early-posttransplant group, but this was associated with a supranormal drive to mitochondrial ATP production, as reflected by the significantly higher end-exercise [ADP] in the lateposttransplant group. However, compared with normal control subjects, the late-posttransplant group still had a reduced exercise duration and a lower PCr/(PCr+Pi) at submaximal exercise (both P<.05).
Discussion
The present study demonstrates that the metabolic abnormalities in exercising skeletal muscle in patients with congestive heart failure persist, in large part, after successful heart transplantation. In the early-posttransplantation group studied a mean of 4 months after successful heart transplantation, the increased acidification and PCr utilization during exercise, as well as the reduced PCr resynthesis rate in recovery, suggest a continued decreased capacity for oxidative metabolism and a continued increased reliance on glycolysis. 
Early
Although the late-posttransplant group showed some evidence of improvement in exercising skeletal muscle metabolic measures, one of the most striking findings was the continued abnormal exercise responses in this group, who were a mean of 15 months and a median of 10 months after transplantation. The persistently abnormal responses in the late-posttransplant group included a decreased maximal exercise duration (P<.05 versus normal subjects), a persistently reduced submaximal exercise PCr/(PCr+Pi) (P<.05), and a trend toward a lower submaximal pH and Vm,. In addition, although the rate of PCr resynthesis in the late group was not significantly different from control subjects, the PCr resynthesis rate was maintained only by a higher than normal end-exercise [ADP], which is the drive for mitochondrial ATP production. This is reflected in the Vmax which is slightly reduced.
The explanation for the persistent metabolic abnormalities after otherwise successful heart transplantation is not clear from this study. There are several possibilities, but none sufficiently explain our findings. First, the skeletal muscle defect may be permanent and irreversible by the time that a patient is ill enough to require transplantation. Arguing against this possibility is the clear-cut symptomatic improvement and relief of fatigue that occur after transplantation. In addition, we and others have demonstrated that in congestive heart failure, the metabolic defect is not fixed but can be improved by exercise training.15-17 A second possibility is that the forearm skeletal muscle continues to be FIG 3. Bar graph shows that PCr/(PCr+Pi) at submaximal exercise was significantly different between groups, with the pretransplant (Pre), early-posttransplant, and late-posttransplant groups all having lower values than normal subjects (all P<.05). PCr indicates phosphocreatine; Pi, inorganic phosphate. Late deconditioned. As noted above, several studies have documented that the metabolic abnormality of exercising skeletal muscle in heart failure can be ameliorated by training; thus, continued inactivity after transplantation potentially could lead to persistent skeletal muscle defects. We think this explanation is unlikely, since nearly all the posttransplant patients had resumed a normal lifestyle. In addition, patients with the chronic fatigue syndrome have no consistent abnormalities by 31P magnetic resonance spectroscopy exercise testing of their forearm muscles.32 Thus, even marked inactivity, as occurs in patients with the chronic fatigue syndrome, does not lead to abnormalities of forearm metabolism during exercise. A third potential explanation for our findings might be reduced blood flow to the exercising muscles. Although reduced blood flow can cause metabolic abnormalities in exercising muscle,33 reduced blood flow alone is unlikely to explain our findings in the patient groups for several reasons: (1) plethysmographic measures of forearm blood flow have not been different in patients with heart failure and control subjects in several studies; (2) differences between patients with heart failure and control subjects persist even during ischemic exercise5611; (3) forearm vasodilator reserve returns to normal by 4 months after transplantation34; and (4) submaximal supine exercise cardiac output is normal late after transplantation. 35 A fourth potential explanation for the persistent muscle abnormalities might be side effects caused by the antirejection medications required after transplanta- described. Thus, although overt skeletal muscle damage caused by cyclosporine is quite rare, it is possible that cyclosporine contributes to milder subclinical defects that are detectable by spectroscopic testing. Further studies of the effects of cyclosporine on skeletal muscle are needed.
Clinical Implications
Exercise capacity, although improved after heart transplantation, does not totally normalize.18-21 In a study by Stevenson et al,2' maximal oxygen uptake was only 60% of predicted normal in patients studied a mean of 14 months after transplantation. The causes of reduced exercise capacity are unclear. Possible causes include central defects (reduced maximal heart rate, stroke volume, and cardiac output and increased myocardial stiffness). Additionally, the present study raises the possibility that peripheral skeletal muscle defects, which do not reverse with otherwise successful heart transplantation, might also contribute to abnormal exercise capacity.
